Centrica and X-energy Advance UK Nuclear Plans as Regulatory Review Begins
Key Facts
In a move reflecting the United Kingdom's push to bolster energy security through advanced nuclear technology, regulators have formally commenced the design review process for the Xe-100 reactor. The UK government directed regulators to begin the Generic Design Assessment (GDA) for X-energy’s advanced reactor, marking a critical step toward commercial licensing. This milestone coincides with the one-year anniversary of the partnership between Centrica and X-energy to deploy small modular reactors across the country.
The partnership between Centrica and X-energy aims to deploy up to 6 GW of new nuclear capacity in Britain. Per market data, Centrica's stock (CNA.L) stood at 146.7p at the close of September 15, 2026, fluctuating between a day high of 147.3p and a low of 145.8p. This regulatory advancement is considered a significant milestone for Centrica's long-term clean energy strategy, although full commercial deployment remains several years away according to analyst assessments.
Investors should monitor the GDA timeline as a primary catalyst for the stock, which closed at 146.7p on September 15, 2026. While the upcoming economic calendar does not list immediate nuclear-specific catalysts, the broader UK market continues to digest recent macroeconomic data, including the 0.4% monthly GDP growth reported on September 11, which may influence industrial energy policy and investment sentiment.